About BioMEMS and microsystems
BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery.
Technavio's analysts forecast the global BioMEMS and microsystems market in the healthcare sector to grow at a CAGR of 25.1% over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global BioMEMS and microsystems market in the healthcare sector for the period 2015-2019. The market has been segmented based on the following:
Technavio Announces the Publication of its Research Report – Global BioMEMS and Microsystem Market in the Healthcare Sector 2015-2019
Technavio recognizes the following companies as the key players in the Global BioMEMS and Microsystem Market in the Healthcare Sector: Given Imaging, Cepheid, Bluechiip and Integrated Sensing Systems
Other prominent vendors in the market are: Becton, Dickinson and Company, Boston Scientific, CapitalBio, e2v, Heimann Sensor, Lepu Medical, Mec, Micron Technology, Nanopass, OMRON, Teledyne DALSA and United Gene High-Tech Group
Commenting on the report, an analyst from Technavio’s team said: “BioMEMS can be implanted into a specific region of the body for localized drug therapy. Once a drug is released into the body, the delivery system takes control of the dosage requirements, thus maximizing the effect of the drug and reducing the possibilities of side-effects. BioMEMS systems have sensors, which monitor the drug release profile and efficiency of the drug administered through specific marker molecules. Any regression of the disease being treated can be identified using these markers.”
According to the report, rising healthcare costs have necessitated the increase in demand for health monitoring equipment, which are a cheaper alternative to traditional routine check-ups. Sensors can be installed around homes to keep track of daily activities, and any unusual change in activities is reported. Such sensors are also installed, albeit for a shorter period, to monitor sick patients. It provides accurate and reliable data, which helps in health evaluation. This technology can be highly beneficial for the aging population as they can undergo regular checkups and assistance can be provided in a timely manner.
Further, the report states that lack of awareness about BioMEMS is affecting the growth of the market.
Given Imaging, Cepheid, Bluechiip, Integrated Sensing Systems, Becton, Dickinson and Company, Boston Scientific, CapitalBio, e2v, Heimann Sensor, Lepu Medical, Mec, Micron Technology, Nanopass, OMRON, Teledyne DALSA, United Gene High-Tech Group